Clinical comments on prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma (OSCC)

Jayaraj R 1 , Shetty S 2 , Kumaraswamy C 3 , Raghul S 4 , Gothandam KM 5 , Raymond G 6 Show all authors , Ravishankar RM 7 , Shaw P 8

Affiliations 

  • 1 Northern Territory Institute of Research and Training, Darwin, Northern Territory 0909, Australia; Department of Artificial Intelligence, Nanjing University of Information Science and Technology (NUIST), Jiangsu, China
  • 2 Oral Oncology, Manipal College of Dental Sciences, Mangalore, Manipal Academy of Higher Education. A Constituent of MAHE, India. Electronic address: sameep.shetty@manipal.edu
  • 3 School of Public Health, The University of Adelaide, North Terrace Campus, Adelaide, SA 5005, Australia
  • 4 School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India
  • 5 School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India
  • 6 Preclinical Education, Flinders University Northern Territory Medical Program, CDU Campus, Ellengowan Drive, Darwin, Northern Territory 0909, Australia. Electronic address: greg.raymond@flinders.edu.au
  • 7 Department of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: mravishankarram@um.edu.my
  • 8 Department of Artificial Intelligence, Nanjing University of Information Science and Technology (NUIST), Jiangsu, China. Electronic address: 100001@nuist.edu.cn
Oral Oncol, 2020 Dec;111:104886.
PMID: 32684328 DOI: 10.1016/j.oraloncology.2020.104886

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications